Literature DB >> 30678969

Multifunctional nanoclusters of NaYF4:Yb3+,Er3+ upconversion nanoparticle and gold nanorod for simultaneous imaging and targeted chemotherapy of bladder cancer.

Suehyun K Cho1, Lih-Jen Su2, Chenchen Mao1, Connor D Wolenski1, Thomas W Flaig2, Wounjhang Park3.   

Abstract

This paper reports successful synthesis of multifunctional nanoclusters of upconversion nanoparticle (UCNP) and gold nanorod (AuNR) through a PEGylation process. UCNPs emit visible luminescence under near-infrared excitation, producing high-contrast images with no background fluorescence. When coupled with AuNRs, the resulting UCNP-AuNR multifunctional nanoclusters are capable of simultaneous detection and treatment of bladder cancer. These UCNP-AuNR nanoclusters are further functionalized with antibodies to epidermal growth factor receptor (EGFR) to target bladder cancer cells known to overexpress EGFRs. This paper demonstrates, for the first time, efficient targeting of bladder cancer cells with UCNP-AuNR nanoclusters. In addition to high-contrast imaging and consequently high sensitivity detection of bladder cancer cells, highly selective optoporation-assisted chemotherapy was accomplished using a dosage of chemotherapy agent significantly lower than any previous reports, within a clinically relevant incubation time window. These results are highly relevant to the eventual human application in which the nanoclusters and chemotherapy drugs will be directly instilled in bladder via urinary catheter.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bladder Cancer; Gold Nanorod; Luminescence upconversion; Optoporation; Surface Plasmon

Mesh:

Substances:

Year:  2018        PMID: 30678969      PMCID: PMC6407122          DOI: 10.1016/j.msec.2018.12.113

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  30 in total

1.  Upconversion and anti-Stokes processes with f and d ions in solids.

Authors:  François Auzel
Journal:  Chem Rev       Date:  2004-01       Impact factor: 60.622

2.  Non-blinking and photostable upconverted luminescence from single lanthanide-doped nanocrystals.

Authors:  Shiwei Wu; Gang Han; Delia J Milliron; Shaul Aloni; Virginia Altoe; Dmitri V Talapin; Bruce E Cohen; P James Schuck
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-18       Impact factor: 11.205

3.  Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells.

Authors:  Dev K Chatterjee; Zhang Yong
Journal:  Nanomedicine (Lond)       Date:  2008-02       Impact factor: 5.307

4.  An efficient and user-friendly method for the synthesis of hexagonal-phase NaYF(4):Yb, Er/Tm nanocrystals with controllable shape and upconversion fluorescence.

Authors:  Zhengquan Li; Yong Zhang
Journal:  Nanotechnology       Date:  2008-07-16       Impact factor: 3.874

5.  Plasmon-enhanced upconversion in single NaYF4:Yb3+/Er3+ codoped nanocrystals.

Authors:  Stefan Schietinger; Thomas Aichele; Hai-Qiao Wang; Thomas Nann; Oliver Benson
Journal:  Nano Lett       Date:  2010-01       Impact factor: 11.189

6.  Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy.

Authors:  Chao Wang; Liang Cheng; Zhuang Liu
Journal:  Biomaterials       Date:  2010-10-20       Impact factor: 12.479

7.  Expression of the epidermal growth factor receptor family in normal and malignant urothelium.

Authors:  Ranveig Røtterud; Jahn Marthin Nesland; Aasmund Berner; Sophie D Fosså
Journal:  BJU Int       Date:  2005-06       Impact factor: 5.588

8.  Autofluorescence of viable cultured mammalian cells.

Authors:  J E Aubin
Journal:  J Histochem Cytochem       Date:  1979-01       Impact factor: 2.479

9.  Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.

Authors:  Zivko Popov; Sixtina Gil-Diez-De-Medina; Vincent Ravery; Andras Hoznek; Sylvie Bastuji-Garin; Marie-Aude Lefrere-Belda; Claude C Abbou; Dominique K Chopin
Journal:  Urol Oncol       Date:  2004 Mar-Apr       Impact factor: 3.498

10.  Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.

Authors:  Z Tang; R Du; S Jiang; C Wu; D S Barkauskas; J Richey; J Molter; M Lam; C Flask; S Gerson; A Dowlati; L Liu; Z Lee; B Halmos; Y Wang; J A Kern; P C Ma
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

View more
  1 in total

Review 1.  Application of nanotechnology in the diagnosis and treatment of bladder cancer.

Authors:  Yadong Xu; Cheng Luo; Jieqiong Wang; Lingwu Chen; Junxing Chen; Tianfeng Chen; Qinsong Zeng
Journal:  J Nanobiotechnology       Date:  2021-11-27       Impact factor: 10.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.